Axtria® Named By NJBIZ As 2021 Top 250 Privately Held Company, Jumping 23 Spots In Rankings From 2020

    Berkley Heights, NJ, August 30, 2021 – Despite the global COVID-19 pandemic, Axtria’s continued fast growth in the past year has again earned its recognition by NJBIZ as one of 2021’s top privately-held companies in New Jersey.

    Marking the fifth time Axtria has been featured on the NJBIZ annual ranking and moving up 23 places on the list from #76 to #53 from 2020, the company continues to be recognized for its steady financial growth and new employee hiring in the marketplace. Axtria has previously been on NJBIZ’s “Fast 50” list seven years in a row as well as a participant in its “Business of the Year” program.

    From 2020-2021, Axtria grew its revenues by 50%, secured a $150 million investment from Bain Capital (Axtria Secures $150 Million Growth Investment from Bain Capital Tech Opportunities (, initiated a plan to expand its workforce by 1,000 employees, and initiated employee-driven fundraising and medical support programs in the U.S. and India that generated $175,000.00 for COVID-19 victims.

    “We continue to be honored over the past several years by NJBIZ’s recognition of our significant pace of growth, expanding our New Jersey workforce, and overall contribution to the growth of the New Jersey business sector,” said Jassi Chadha, CEO & President of Axtria. “We are proud to be headquartered in New Jersey and look forward to continuing to invest, build, and scale our expertise in cutting-edge cloud and data analytics software technology for the life sciences sector to elevate our New Jersey roots to the national stage in our industry.”

    Contact Information

    Neha Garg
    Axtria, Inc.

    About Axtria

    Axtria is a global provider of award-winning cloud software and data analytics to the life sciences industry. Axtria’s solutions are used to digitally transform the entire product commercialization process, supporting RWE/HEOR, medical affairs, pricing and market access, product launch and post-launch, and marketing and sales operations to drive growth and improve healthcare outcomes for patients. Our focus is on delivering solutions that help pharmaceutical, medical device, and diagnostics companies complete the journey from data to insights to action and get superior returns from their investments. As a participant of the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption and taking actions that advance societal goals. For more information, visit

    Connect with Axtria on: